Re-Pharm’s goal is to lower the risks and costs associated with drug discovery in order to bring compounds to market in areas of unmet medical need.
Re-Pharm compounds have known pharmacology and safety. We identify therapeutic opportunities with a sound market opportunity.
We combine our expertise in pharmacology and disease biology with patented computational chemistry software to identify candidate compounds that match our selection criteria:
- areas of unmet medical need
- accessible market and patent space
- readily available assays to determine activity
- a clear and straightforward development path to clinic.
We use standard biological assays for a rapid and cost effective identification of new activity.
Using this approach we have built a pipeline of candidate compounds in a number of therapeutic areas.